Suppr超能文献

不同 FGF 配体激活成纤维细胞生长因子受体的定量和定性差异。

Quantitative and qualitative differences in the activation of a fibroblast growth factor receptor by different FGF ligands.

机构信息

Department of Materials Science and Engineering and Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, MD 21218, USA.

Department of Biology, Faculty of Medicine, Masaryk University, Brno 62500, Czech Republic; International Clinical Research Center, St. Anne's University Hospital, Brno 65691, Czech Republic.

出版信息

Cytokine Growth Factor Rev. 2024 Aug;78:77-84. doi: 10.1016/j.cytogfr.2024.07.002. Epub 2024 Jul 9.

Abstract

The FGF system is the most complex of all receptor tyrosine kinase signaling networks with 18 FGF ligands and four FGFRs that deliver morphogenic signals to pattern most embryonic structures. Even when a single FGFR is expressed in the tissue, different FGFs can trigger dramatically different biological responses via this receptor. Here we show both quantitative and qualitative differences in the signaling of one of the FGF receptors, FGFR1c, in response to different FGFs. We provide an overview of the recent discovery that FGFs engage in biased signaling via FGFR1c. We discuss the concept of ligand bias, which represents qualitative differences in signaling as it is a measure of differential ligand preferences for different downstream responses. We show how FGF ligand bias manifests in functional data in cultured chondrocyte cells. We argue that FGF-ligand bias contributes substantially to FGF-driven developmental processes, along with known differences in FGF expression levels, FGF-FGFR binding coefficients and differences in FGF stability in vivo.

摘要

成纤维细胞生长因子(FGF)系统是所有受体酪氨酸激酶信号网络中最复杂的系统,包含 18 种 FGF 配体和 4 种 FGFR,它们传递形态发生信号,以对大多数胚胎结构进行模式化。即使在组织中仅表达一种 FGFR,不同的 FGF 也可以通过该受体触发截然不同的生物学反应。在这里,我们展示了其中一种 FGF 受体 FGFR1c 在响应不同 FGF 时的信号传递的定量和定性差异。我们提供了一个概述,介绍了最近发现的 FGF 通过 FGFR1c 进行偏倚信号传递的情况。我们讨论了配体偏倚的概念,它代表了信号传递中的定性差异,因为它是衡量不同下游反应的不同配体偏好的指标。我们展示了 FGF 配体偏倚如何在培养的软骨细胞中的功能数据中表现出来。我们认为,FGF-配体偏倚与已知的 FGF 表达水平、FGF-FGFR 结合系数以及体内 FGF 稳定性的差异一起,对 FGF 驱动的发育过程有很大的贡献。

相似文献

1
Quantitative and qualitative differences in the activation of a fibroblast growth factor receptor by different FGF ligands.
Cytokine Growth Factor Rev. 2024 Aug;78:77-84. doi: 10.1016/j.cytogfr.2024.07.002. Epub 2024 Jul 9.
2
Up-regulation and co-expression of fibroblast growth factor receptors in human gastric cancer.
J Cancer Res Clin Oncol. 2000 Sep;126(9):519-28. doi: 10.1007/s004320000128.
3
The diverse dependence of galectin-1 and -8 on multivalency for the modulation of FGFR1 endocytosis.
Cell Commun Signal. 2024 May 15;22(1):270. doi: 10.1186/s12964-024-01661-3.
4
Impact of ligand binding on VEGFR1, VEGFR2, and NRP1 localization in human endothelial cells.
PLoS Comput Biol. 2025 Jul 16;21(7):e1013254. doi: 10.1371/journal.pcbi.1013254. eCollection 2025 Jul.
7
The Black Book of Psychotropic Dosing and Monitoring.
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
8
T-bet expressing Tr1 cells driven by dietary signals dominate the small intestinal immune landscape.
bioRxiv. 2025 Jul 4:2025.06.30.662190. doi: 10.1101/2025.06.30.662190.
10
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.

引用本文的文献

1
Differential association of EphA2 intracellular regions in biased signaling.
J Biol Chem. 2025 Apr;301(4):108383. doi: 10.1016/j.jbc.2025.108383. Epub 2025 Mar 4.
3
Cordycepin Activates Autophagy to Suppress FGF9-induced TM3 Mouse Leydig Progenitor Cell Proliferation.
Cancer Genomics Proteomics. 2024 Nov-Dec;21(6):630-644. doi: 10.21873/cgp.20479.

本文引用的文献

1
Ligand bias underlies differential signaling of multiple FGFs via FGFR1.
Elife. 2024 Apr 3;12:RP88144. doi: 10.7554/eLife.88144.
2
Computer-aided engineering of stabilized fibroblast growth factor 21.
Comput Struct Biotechnol J. 2024 Feb 7;23:942-951. doi: 10.1016/j.csbj.2024.02.001. eCollection 2024 Dec.
5
Cyclic and dimeric fibroblast growth factor 2 variants with high biomedical potential.
Int J Biol Macromol. 2022 Oct 1;218:243-258. doi: 10.1016/j.ijbiomac.2022.07.105. Epub 2022 Jul 22.
6
Ligands with different dimeric configurations potently activate the EphA2 receptor and reveal its potential for biased signaling.
iScience. 2022 Feb 4;25(3):103870. doi: 10.1016/j.isci.2022.103870. eCollection 2022 Mar 18.
7
Community guidelines for GPCR ligand bias: IUPHAR review 32.
Br J Pharmacol. 2022 Jul;179(14):3651-3674. doi: 10.1111/bph.15811. Epub 2022 Mar 27.
8
Fibroblast Growth Factor 2 Conjugated with Monomethyl Auristatin E Inhibits Tumor Growth in a Mouse Model.
Biomacromolecules. 2021 Oct 11;22(10):4169-4180. doi: 10.1021/acs.biomac.1c00662. Epub 2021 Sep 20.
9
Pondering the mechanism of receptor tyrosine kinase activation: The case for ligand-specific dimer microstate ensembles.
Curr Opin Struct Biol. 2021 Dec;71:193-199. doi: 10.1016/j.sbi.2021.07.003. Epub 2021 Aug 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验